Mechanism of microRNA‐22 in regulating neuroinflammation in Alzheimer’s disease
Abstract Background Study on the expression of miRNA‐22 in serum of Alzheimer's disease (AD) patients and the mechanism of neuroinflammation regulation. Methods ELISA assay was used to detect the serum level of inflammatory factors, including interleukin‐1β (IL‐1β), interleukin‐18 (IL‐18), and...
Main Authors: | Chenyang Han, Li Guo, Yi Yang, Qiaobing Guan, Heping Shen, Yongjia Sheng, Qingcai Jiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.1627 |
Similar Items
-
Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer’s disease
by: Heping Shen, et al.
Published: (2021-04-01) -
Neuroinflammation in Ischemic Stroke: Focus on MicroRNA-mediated Polarization of Microglia
by: Lu Lian, et al.
Published: (2021-01-01) -
Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation
by: Dora eBrites, et al.
Published: (2015-12-01) -
The Regulation of microRNAs in Alzheimer's Disease
by: Xianjuan Kou, et al.
Published: (2020-04-01) -
MicroRNA-22 Downregulation by Atorvastatin in a Mouse Model of Cardiac Hypertrophy: a new Mechanism for Antihypertrophic Intervention
by: Yingfeng Tu, et al.
Published: (2013-07-01)